Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas M Wheeler

Showing results (91-100 of 143) with videos related to

Pageof 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2004
Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomasDonald C Malins, Naomi K Gilman, Virginia M Green, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2022
Strong Job Market for Pathologists: Results From the 2021 College of American Pathologists Practice Leader SurveyDavid J Gross, Stanley J Robboy, Michael B Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancerMichael W Kattan, Shahrokh F Shariat, Ben Andrews, et al.
The Journal of Urology|March 15, 2013
Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processingMarc A Bjurlin, H Ballentine Carter, Paul Schellhammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohortSalahaldin A Tahir, Anna Frolov, Teresa G Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Cancer-related axonogenesis and neurogenesis in prostate cancerGustavo E Ayala, Hong Dai, Michael Powell, et al.
Cancer Research|August 9, 2003
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodesShahrokh F Shariat, Martine P Roudier, George E Wilcox, et al.
Urology|December 11, 2007
Prognostic significance of location of positive margins in radical prostatectomy specimensJames A Eastham, Kentaro Kuroiwa, Makoto Ohori, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimensMahul Amin, Liliane Boccon-Gibod, Lars Egevad, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimensJonathan I Epstein, Mahul Amin, Liliane Boccon-Gibod, et al.
Pageof 15

Showing results (91-100 of 143) with videos related to

Sort By:
Pageof 15
Proceedings of the National Academy of Sciences of the United States of America|July 29, 2004
Metastatic cancer DNA phenotype identified in normal tissues surrounding metastasizing prostate carcinomasDonald C Malins, Naomi K Gilman, Virginia M Green, et al.
Archives of Pathology & Laboratory Medicine|July 1, 2022
Strong Job Market for Pathologists: Results From the 2021 College of American Pathologists Practice Leader SurveyDavid J Gross, Stanley J Robboy, Michael B Cohen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
The addition of interleukin-6 soluble receptor and transforming growth factor beta1 improves a preoperative nomogram for predicting biochemical progression in patients with clinically localized prostate cancerMichael W Kattan, Shahrokh F Shariat, Ben Andrews, et al.
The Journal of Urology|March 15, 2013
Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processingMarc A Bjurlin, H Ballentine Carter, Paul Schellhammer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2006
Preoperative serum caveolin-1 as a prognostic marker for recurrence in a radical prostatectomy cohortSalahaldin A Tahir, Anna Frolov, Teresa G Hayes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Cancer-related axonogenesis and neurogenesis in prostate cancerGustavo E Ayala, Hong Dai, Michael Powell, et al.
Cancer Research|August 9, 2003
Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodesShahrokh F Shariat, Martine P Roudier, George E Wilcox, et al.
Urology|December 11, 2007
Prognostic significance of location of positive margins in radical prostatectomy specimensJames A Eastham, Kentaro Kuroiwa, Makoto Ohori, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimensMahul Amin, Liliane Boccon-Gibod, Lars Egevad, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Prognostic factors and reporting of prostate carcinoma in radical prostatectomy and pelvic lymphadenectomy specimensJonathan I Epstein, Mahul Amin, Liliane Boccon-Gibod, et al.
Pageof 15